Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don't see this in the filings --
Of course the 8k that was referenced in the PR was filed. ANYONE with industry knowledge knows that forms electronically filed with the SEC can take up to 72 hours to be accepted, reviewed and posted.
People are grasping at straws.
CHP --
Answers are simple to get -- I called and asked the company.
I was told that the 19,207,420 shares of common stock issued in private subscription sale referenced in the 10K are RESTRICTED.
I see no actual error in the filing (I definitely don't assume that as you state), but I am not an auditor or accountant. I see that they gave defining specifics on the Seaside transaction - nothing else.
As I said before "Your negativity is getting the better of you and clouding your judgement."
You replied ".... I have stated facts and reasonably-deduced theories...."
I disagree with your "reasonably-deduced theories" and inaccurate statements. If you know the rules as well as you let on, you would have NEVER reasonably deduced that the shares stated were free trading.
To the "I call it as I see it" statement, I say -- so do I.
Why would you say that the 19 million shares are not restricted?
Just because it does not specifically say RESTRICTED or FREE Trading in the description of the shares, you are assuming that they would be free trading. That would be a silly assumption. Under a normal PPM the shares are restricted. If you have a question about the shares you should talk to the company and not make such a negative assumption.
I think it is a great positive if management sold shares to long term investors that believed in the company and it's business plan as opposed to the typical funders that view OTC companies as a transaction and not a partner.
Your negativity is getting the better of you and clouding your judgement.
With all the admins deleting posts recently (most deletions are not justified to me) -- how is this post by CB viewed as on topic?? How did it ever get reinstated??
There is a great biased from the admins. Why is this post still here? There is no mention of the company, only a veil threat to a former poster.
I am disappointed with the admins on this board and their controlling attitude.
This will be deleted quickly lol
The notes you have outlined have a maturity date of 1 year from issuance but are convertible after 6 months. As history as shown, the people that lend for the convertibles almost always convert close the day they become available (6 month anniversary).
You suggesting that the leopard would all the sudden change its spots and wait a full year is very illogical as it pertains to reality.
Wholesale RX can take deliveries, pack, ship and collect out of that space just fine. I mean -- it is Tennessee, but I am sure they have internet and phone service -- lol!!!
The sales people are probably outbound reps -- not in house.
Not really sure what is wrong with them working out of a retail space. What point are you trying to make?
I have run multi-million dollar companies out of the owner's house/basement before.
Not sure I see the problem here.
If the price never hits .10, Tink gets zero shares and the stock performs -- he is out in the cold. It is called risk/reward.
NO ONE HAS A CRYSTAL BALL.
It is a personal decision for everyone. I have made mine. My decision was to buy above .10 -- but that is not right for everyone.
Others need to make their own decision and live with the consequences.
this is from a broker friend of mine
At OTC Market's (Pink's) request, Fidessa will be connecting to their DR site for the remainder of the day. Although initially targetting 10:00 ET for open, the exchange has delayed that further and currently has no definite ETA for market open. We will be providing further updates as the become available from the exchange.
Regards,
Fidessa Support
dlewisfl --
You are awful negative for a shareholder. Why would you ever talk like that about an investment of yours? If you are so negative -- why don't you lighten your mental load and sell (you have said you have a good profit at this point) and move on?
You bring up some very good points but in such a negative light that something definitely is not ringing true with you.
Why are you here??
From the 8k
This is what GEM thinks of SCRC and the future. A very good sign of things to come.
In connection with entering into the financing agreement, the Registrant issued to 590 Partners Capital, LLC ("590 Partners") and GEM Global six (6) common stock purchase warrants to purchase collectively up to ten million (10,000,000) shares of the Registrant's common stock. Each of GEM Global and 590 Partners received (i) a warrant exercisable to purchase 2,000,000 shares of common stock at an exercise price of $0.41, (ii) a warrant exercisable to purchase 1,500,000 shares of common stock at an exercise price of $0.55 and (iii) a warrant exercisable to purchase 1,500,000 shares of common stock at an exercise price of $0.75. All of the warrants expire on October 10, 2018 and are only exercisable on a cash basis (they do not contain any cashless exercise provisions). Additionally, the Registrant granted registration rights to 590 Partners and GEM Global to register the resale of the shares underlying the warrants.
You are on a website not associated with the company. If you want answers about the company -- call them. Posting here about this is useless.
Industrial Nanotech, Inc.
1925 Trade Center Way, Suite 1
Naples, FL 34109
US & Canada (Toll Free): 800-767-3998
US & International: 1-239-254-0346
Fax (US & Can.): 1-239-254-1381
contact@nansulate.com
Trueheart -- you are a smart man (or woman)
.18 a month is slow and steady and definitely a great way to grow! That is just about .01 a day on average.
People looking for .05-.10 a day set themselves up for disappointment and violent corrections.
ScripsAmerica Enters Pharmaceutical Distribution Agreement Anticipated to Generate Multi-Million Dollar Revenues
GlobeNewswire logo unavailable
07/16 12:30:09
LANGHORNE, Pa., July 16, 2013 (GLOBE NEWSWIRE) -- ScripsAmerica Inc. (OTCBB:SCRC), a supplier of prescription, OTC and nutraceutical drugs, today announced that the Company has signed an agreement with a network buying group to provide prescription and OTC drugs to its clients which include over 700 independent pharmacies with GPO relations.
A GPO (group purchasing organization) is an entity that leverages the purchasing power of a group of businesses to obtain discounts from vendors based on their collective buying power.
Additionally, ScripsAmerica has secured the services of an industry leading pharmaceutical logistics company to store and facilitate the distribution of these products to the independent pharmacies. Per the agreement, ScripsAmerica will order from the manufacturers and have the products shipped to the fully licensed logistics company who will distribute the drugs to the network's pharmacies as ordered.
This "pick and pack" operation allows ScripsAmerica to leverage its purchasing power and supply its pharmacies with the quantity of products they need at competitive prices.
"ScripsAmerica is very excited to announce this relationship which we anticipate will have very positive revenue implications for the company due to its strong business model. We will now offer a unique distribution avenue to potentially several hundred independent pharmacies for prescription drugs they would not otherwise have access to," commented ScripsAmerica's CEO, Bob Schneiderman.
"We will initially distribute products to between 35 and 50 pharmacies within the network, however within twelve months, ScripsAmerica could provide pharmaceuticals to the company's entire network. Because of this, we estimate generating significant revenue during the first six to twelve months of the agreement as we scale up our operations," continued Schneiderman.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. delivers pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and home care agencies.
For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: 888-959-7095
No one is helping out BKRT and CSTI tooooooo bad!!
"I'm living in a van down by the river!!!"
Another green day -- whether it is .01 or .15 -- it turns the screws on the shorters and the guys that ALWAYS take advantage of the market with no regard for any company or investor.
I hope they go belly up and have to live in a van down by the river!!
Jh0000
Welcome to Ihub. You are a new member to ihub as of 7:56pm tonight. Somehow you come directly to this board and spew baseless negativity.
I would guess that you don't have any particular agenda. Do you? Too transparent. Good luck with buying back your short.
As far as news, keep in mind that this is not a promo. Real companies don't put out fluff news every 2 days to keep stockholders happy.
I don't want to see that the CEO and CFO had chicken salad for lunch - or some obscure person that joined the Board of Directors. When there is something real that is advancing with the Scrip's business, I expect to see a press release.
This stock run has been based on accumulation and future value - not fluff pr's.
Money Flow opened negative -- on BKRT's selling and quickly went positive. OBV went from -28000 shares to +40778 shares that shows that we have 40778 more shares bought than sold today. That is HUGE at .80 See you at 1.00 anytime now.
178 boardmarks and we didn't even hit .75 Celtics -- you were WAYYYYYYYYY off!!
Back to the drawing board for you!!
I love this stock!!!
Now promo people are trying to jump on our bandwagon and claim our success.
NO ONE HAS BEEN PAID!!! Read the disclaimers.
Celtics -- the word is spreading.
I was at a restaurant on July 4th and sat next to someone and all he could do is talk about stocks -- he brought up SCRC. His enthusiasm was incredible! He spoke about telling all his friends and getting them into the Scrips before it hit $1.00. He said all the right things about SCRC --- low float, real revs, unbelievable growth, etc, etc, etc.
He said he was going to buy more -- I bet he bought more yesterday.
Now my thoughts. Right now --- Supply is low and the demand is high and getting much higher. I feel that one thing will happen -- $1.00 very soon. $4.00 soon enough. If they bring out 1-2 new Rapimed products next year, I see $75 mil revs in 2-3 yrs with maybe 100 million OS.
Using your formula of 12x revs, this is what I see is possible:
$75 mill x 12 (industry standard is 12-15) = $900 mil market cap / 100 mill shares = $9.00 -- maybe by the end of 2015
This would easily qualify for an uplisting to Nasdaq.
Thoughts??
Realize steady small gains.
Today we gained 9% -- Yes it is only .04 but that is unbelievable! We don't need 10-20% gains every day -- just small consistent gains. The float is largely spoken for. Any additional buying pressure lets us keep moving it up. Remember -- above .51 is blue sky. There should be VERY limited selling pressure (only sellers that already own the stock from lower)
TELL YOUR FRIENDS AND NEIGHBORS
At only a 3% gain per day -- this is what the price looks like over time. 22 days per month. I went out 2 months.
Day Price
1 0.480
2 0.494
3 0.509
4 0.525
5 0.540
6 0.556
7 0.573
8 0.590
9 0.608
10 0.626
11 0.645
12 0.664
13 0.684
14 0.705
15 0.726
16 0.748
17 0.770
18 0.793
19 0.817
20 0.842
21 0.867
22 0.893 End of July
23 0.920
24 0.947
25 0.976
26 1.005
27 1.035
28 1.066
29 1.098
30 1.131
31 1.165
32 1.200
33 1.236
34 1.273
35 1.311
36 1.351
37 1.391
38 1.433
39 1.476
40 1.520
41 1.566
42 1.613
43 1.661
44 1.711 End of August
Look again. You are on there.
3rd from the bottom.
440k on the bid --- WOW!!
News out
http://finance.yahoo.com/news/gemini-explorations-president-ceo-recaps-133000275.html
Gemini Explorations' President and CEO Recaps Successful Year and Highlights Drivers for Growth in 2013
10 minutes ago
FT. LAUDERDALE, FLORIDA -- Gemini Explorations Inc.'s (GMXS) President and Chief Executive Officer, Michael Hill, today provided a recap of the Company's progress in 2012, highlighting recent developments as drivers for growth in 2013 and cause ?for optimism among its shareholders.
Mr. Hill commented, "2012 was a successful year for Gemini Explorations as the Company has made significant progress toward operating profitable gold mines in the Los Andes Sotomayor Gold Belt. This is a very exciting time for ?the company and its shareholders as we begin 2013, having recently secured an exclusive option to acquire an advanced stage milling and processing plant that could greatly accelerate the development our La Tapada gold project by increasing accessibility, hence lowering costs for transporting equipment to the property.”?
“Furthermore, we are very pleased with the sampling results for both our properties, which indicate that they contain a high percentage of free gold, excellent consistency and great potential for additional mineralized zones and vein systems for potential sampling and mining," continued Hill.
In May 2012, Gemini Explorations formed a wholly owned Colombian subsidiary named Minera Gemini SA ('MGS') that holds all of Gemini's Colombian mining concessions and interests in order to streamline and facilitate future mineral property acquisitions as well as mining, permitting and banking procedures. ??Shortly following, the Company announced positive sampling results from its ?La Tapada Gold Project in the El Bagre-Zargoza mining district, with samples taken from the principal vein ranging up to 243 g/tonne Au with an average ?grade of 25.87 g/tonne and showing excellent consistency overall. Recently, Gemini announced positive sampling results from its La Planada Gold Project, which has highly visible surface mineralization and excellent rock exposure ?for open pit mining.
About Gemini Explorations, Inc.
Gemini Explorations is focused on the development of two highly prospective gold projects in Colombia including a potential 3 million ounce deposit in the Los Andes Sotomayor Gold Belt with a potential asset value of approximately $4 billion at today's gold prices. Capitalizing on smart acquisitions, modern production techniques, deep industry expertise and the strong bull market for gold, Gemini Explorations is working quickly to achieve production, growth and value for shareholders. Gemini Explorations has assembled a portfolio of significant land holdings in Colombia's richly mineralized but under-developed gold districts including the La Planada and La Tapada gold properties.Notice
http://finance.yahoo.com/news/scripsamerica-prepays-outstanding-convertible-note-130000747.html
New Castle, DE -- February 4, 2013 - ScripsAmerica Inc. (SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company has prepaid an outstanding convertible promissory note with a principal amount of $63,000, held by Asher Enterprises, Inc.
The convertible note has an 8% interest rate per annum and was issued in August 2012 as part of a securities purchase agreement between ScripsAmerica and Asher Enterprises. The Note has a maturity date of May 8, 2013, however on or after February 2, 2013, the principal and all accrued but unpaid interest and any other amounts due under the Note are convertible into shares of the Company’s common stock at a specified discount.
“The prepayment of this Note has removed any potential dilutive effects that it could have on our stock if it were to be converted. It is very important for ScripsAmerica to continually protect and increase our shareholder value, particularly at a time when we project significant growth based on our RapiMed product launch and acquisition of Marlex Pharmaceuticals,” commented ScripsAmerica’s CEO, Bob Schneiderman.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. delivers pharmaceutical products to a wide range of end users across the health care industry through the largest pharmaceutical distributor in North America, McKesson Corporation. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. Current therapeutic categories serviced by the Company include pain, arthritis, prenatal, urinary, and hormonal replacement drugs. Other customers of ScripsAmerica include Cardinal Health, CutisPharma, Inc., MedVet and the United States Veterans Administration.
For more information, visit www.ScripsAmerica.com.
Wow A hard mailer?? That's fantastic!
Can you scan it and post it? Or give us the weblink that they always have on those mailers?
Thanks in advance!
Are you bitter?????
http://www.wdyinvestorsguide.com/omve/
Who is Michael Stone?
Thanks
found this today at http://omve.net/
http://omve.net/upload/OMVE%20DTC%20SPR%20070611.pdf
one of the PRVCY items at Nordstrom's
http://shop.nordstrom.com/s/prvcy-malibu-hills-bootcut-stretch-jeans-dk-paletto-wash/3069631
MedeFile and Carlisle & Associates Team to Accelerate Industry Adoption of Patient-Centric iPHR Management Solution
BOCA RATON, FL -- (Marketwire) -- 04/19/11 -- MedeFile International, Inc. (OTCQB: MDFI) (PINKSHEETS: MDFI), a leader in Internet-enabled Personal Health Record (iPHR) management solutions, today announced that it has signed an agreement with Carlisle & Associates, a leading healthcare industry consultancy firm, to collaborate on opportunities to accelerate adoption of MedeFile's iPHR system by health plans, health systems, large physician practice groups and other healthcare-related service groups.
Carl Underland, founder and CEO of Carlisle, stated, "Through its development of what we believe to be one of the most robust, intuitive iPHR solutions available in the market, MedeFile now occupies a very critical space in the fast evolving healthcare continuum. By equipping patients with MedeFile's iPHR tools and services, individuals will be able to fully engage with their providers at the point of care, enabling more focused health solutions and outcomes while driving value creation and cost-savings across the full spectrum of care. We look forward to working closely with MedeFile's management team through a symbiotic relationship to bring all stakeholders together in the most efficient manner possible."
Continuing, Underland added, "It is important to note we have validated that there is indeed pent-up and increasing demand for MedeFile's products and services; so it is vital that we exercise optimal diligence in rolling out the solution to the market place with thoughtful, methodical purpose. To that end, we look forward to working closely with MedeFile's management team to most efficiently and effectively respond to this demand, and manage the ramp-up of their operations to accommodate it on an accelerated basis."
Kevin Hauser, Chairman, President and CEO of MedeFile, noted, "Most people agree that traditional healthcare information delivery models do not work and must be changed. As a result, we believe that decision makers at the highest levels of the healthcare system are now turning to technology experts, such as Carlisle & Associates, to find effective solutions that enable the electronic exchange of health information between patients and providers. More importantly, they are recognizing that the logical answer to interconnecting all of a patient's care providers is by centering the responsibility for collecting, digitizing, storing and sharing the medical information generated by the providers with the individual patient. This has long been MedeFile's position. We believe that through our highly innovative and unique iPHR system, we have the power to catalyze the paradigm shift underway in our nation's healthcare system, filling the void and serving as the essential solution that connects all stakeholders in the evolving healthcare ecosystem."
"It was clear to us from our very first meeting with Carlisle that their progressive thinking is ideally aligned with ours. We share the belief that mainstream adoption of MedeFile will benefit individual healthcare consumers, but, just as important, the payers and providers, as well," said Hauser. "Therein lies the exciting opportunity for MedeFile and the basis for our important new relationship with Carlisle."
In closing, Hauser stated, "We are very pleased to be partnering with Carl and his team, who have distinguished themselves as true visionaries and noted thought leaders in the 'new' healthcare environment. With over 60 combined years of experience working at and advising major health plans and providers, their proven expertise in bringing new technologies to the forefront of the healthcare industry is sure to greatly benefit MedeFile and help us to achieve our goal of rapid market adoption for our iPHR solutions by the industry's largest stakeholders. We anticipate that the new business opportunities that Carlisle is bringing to the table will have a pronounced impact on our Company's near term sales growth and long term profit potential."
About Carlisle & Associates
Carlisle and Associates is an innovative healthcare consultancy and business incubator pioneering new models for partnerships between healthcare providers and health plans, that align stakeholder interests, generate enhanced clinical outcomes and generate cost savings. In line with this, Carlisle and Associates also identifies leading healthcare technology companies that enable new healthcare delivery models that coordinate medical information and care, and actively engage patients. For more information, please visit our website at www.carlisle-llc.com.
About MedeFile International, Inc.
Headquartered in South Florida, MedeFile has developed and globally markets a proprietary, patient-centric, iPHR (Internet-enabled Personal Health Record) system for gathering, digitizing and organizing medical records so that individuals can have a comprehensive record of all of their medical visits. MedeFile's primary product is its web-based MedeFile solution, a highly secure system for gathering, maintaining, accessing and sharing personal medical records. Interoperable with most electronic medical record management systems marketed to the healthcare industry, the MedeFile solution is designed to gather all of its members' actual medical records and create a single, comprehensive Electronic Health Record (EHR) that is accessible 24 hours a day, seven days a week by the member and the member's authorized users on any web-enabled device (PC, cell phone, smartphone, e-reader) and portable MedeDrive unit. For more information about MedeFile and its annual subscription-based programs, please visit www.medefile.com.
Safe Harbor Statement Under the Private Securities Litigation Act of 1995
With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of MedeFile could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the Company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates, and unanticipated events such as terrorist activities. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, and such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. For further risk factors associated with our Company, review our SEC filings.
Look at their product called Nanoboost.
Already being used by a few Nascar teams.
Not sure which ones.
Filings done. Go to Pinksheets.com Revenues shown. I only glanced, but it looks like they are profitable.
Nansulate customer case study
Update on previous customer case study in Texas.
http://www.nansulate.com/pdf/CaseStudies/gdavis_casestudy.pdf
NICE NEWS!!
Press Release Source: Industrial Nanotech, Inc. On Wednesday October 6, 2010, 7:57 am EDT
NAPLES, Fla.--(BUSINESS WIRE)-- Industrial Nanotech, Inc. (Pink Sheets:INTK.pk - News), an emerging global leader in nanoscience energy saving solutions, today announced that the sales revenue for the 3 month period ending September 30, 2010 was $1,036,047.00 US.
“The change in the economic conditions that we all experienced in 2009 forced us to rethink, revise and retool our strategy and supplement the reduced revenue from the homeowner Do-It-Yourself market with increased focus on the longer sales cycle major industrial corporations,” states Stuart Burchill, CEO/CTO of Industrial Nanotech, Inc. “Fortunately, we had spent the previous five years diligently and methodically establishing proof of the value added proposition that our technology provides to industries around the world, including the fact that it pays for itself in typically 6-18 months by significantly reducing energy consumption and improving critical sustainability initiatives. Our patented Nansulate product line of award winning, energy saving protective specialty coatings containing a nanotechnology based material are well-documented to provide the combined performance qualities of thermal insulation, corrosion prevention, resistance to mold growth, fire resistance, chemical resistance and lead encapsulation in an environmentally safe, water-based, coating formulation.”
Mr. Burchill continued, “Armed with an innovative, sustainable product line and solid data to back up its extraordinary performance and case studies of companies saving more in just the first year than the product cost them, plus the additional savings year after year, we just worked harder and smarter to get the message out to major global industrial companies and the results are testimonial to our strategy. Our technology simply offers value in cost savings, energy savings and carbon footprint reduction which companies are recognizing and implementing. We have reason to be optimistic about both the near term and long term likelihood of continued growth and success and we look forward to continuing to serve our customers well and enhance our shareholder value.”